SMS Lifesciences India Limited

NSE SMSLIFE.NS

SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -786.90 K

SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities is USD -786.90 K for the year ending March 31, 2024, a -3,829,615.78% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 20.55, a -100.00% change year over year.
  • SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 1.43 M, a 510.26% change year over year.
  • SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -347.78 K, a -121.06% change year over year.
  • SMS Lifesciences India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 1.65 M, a -25.32% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
NSE: SMSLIFE.NS

SMS Lifesciences India Limited

CEO Mr. Talluri Veera Venkata Satyanarayana Murthy
IPO Date Aug. 18, 2017
Location India
Headquarters Plot No. 19-III
Employees 574
Sector Healthcare
Industries
Description

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.

Similar companies

THEMISMED.NS

Themis Medicare Limited

USD 2.64

-2.39%

SMSPHARMA.NS

SMS Pharmaceuticals Limited

USD 2.48

0.36%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.42

-1.59%

ALBERTDAVD.NS

Albert David Limited

USD 13.29

-3.32%

HESTERBIO.NS

Hester Biosciences Limited

USD 21.37

-1.96%

StockViz Staff

February 8, 2025

Any question? Send us an email